Contract Pharma Features Cryoport Growth and Innovation

June 23, 2020

A new Contract Pharma article is all about Cryoport!

The author interviews Mark Sawicki, Chief Commercial Officer and Phil Wilson, Senior Vice President of Global Operations & Supply Chain, who discusses the company's rapid growth alongside the growing cell and gene therapy market, how the global pandemic of COVID-19 is affecting our clients from both a clinical and commercial standpoint, and how we're providing innovative new services, including the first and only validated cleaning and disinfection process in the life sciences industry, Veri-Clean™.

Contract Pharma concludes: "Simply put, without them [Cryoport], new cell and gene therapies can't be developed, or more importantly, delivered to the patients who need them most."

Read the full article here.

Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, cold chain shipping, transportation, Cryoport News, Biopharma Industry News

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC